Tag: CLSD

Blue Horseshoe Stocks: SIG Recap, AXON & More

Signet Jewelers Ltd. SIG – Options Idea

After noticing its solid beat on earnings and reassured guidance yesterday morning in the premarket, we selected a range of options ideas for the SIG chain. Post-earnings options calls have become our bread and butter, and SIG provided yet another example of the reason for that.

Our designated observation range was the SIG Weekly $47.50-50 Calls and all but the 49.50’s enjoyed considerable single-session gains for the day.

$47.50 Calls – Range: 3.70-6.30 – Max Gain: 70%
$48 Calls – Range: 3.21-7.12 – Max Gain: 122%
$48.50 Calls – Range: 3.10-6.00 – Max Gain: 94%
$49 Calls – Range: 2.72-6.17 – Max Gain: 127%
$50 Calls – Range: 1.97-5.21 – Max Gain: 164%
___________

Fresh Options Idea:
Five Below, Inc. FIVE Weekly $90-95 Calls

Axovant Sciences, Inc. AXON

We also included a tag of AXON in yesterday morning’s report, and were met with a pretty good chance for a daily profit there as well. We noticed a slew of Form-4 buys come in on Tuesday, and lo and behold, yesterday the company released news of an $840M+ licensing deal for its Parkinson’s gene therapy.

From a morning low of 3.27, the stock reached a high of 4.64, representing a modest, but very respectable 42% move on the day. We’ll be sure to leave it on our radar in the event that a more sustained move is in the cards.

Extended Watchlist:
ONTX, MRTX, ZS, IMMU, CLWT, CLSD, CLRB

Blue Horseshoe Stocks: SVSN Review & More

Stereo Vision Entertainment, Inc. SVSN

It was roughly six weeks back that we put SVSN on our radars on a routine news scan, and as we always say, it’s better to be early to the party than late. All the way up until last week, the stock wasn’t trading with any real vigor, but things have picked in a huge way, both in volume and price.

From its low at .08 at the beginning of last week, the stock finished out at a high of .89, for an intraweek rip of 1012% This came on the news that the company will file a $50M Real Estate Investment Trust on behalf of its CannaVision subsidiary, with the goal of organically growing cannabis for the purposes of extracting CBD.

Progressive Care, Inc. RXMD

We also want to swing back around to RXMD this morning, which we intially tagged onthe morning of February 22nd. Since that time the stock has exhibited a fairly steady climb up the chart.

We observed a low of .0663 in RXMD on that first day, and as of Friday’s new high of .129, we had watched as the stock rose 95% over a period of just seven trading sessions. It’s streaking to its highest PPS in nearly five years, so it’s safe to say RXMD is in blue sky breakout territory, and we’ll be eager to continue tracking its movements.


Fate Therapeutics, Inc. FATE

We also wanted to recap the solid move we’ve witnessed in FATE, since mentioning the stock toward the end of January. It dipped slightly to a low of 6.76 shortly thereafter, and has since gone a very impressive run.

The stock reached a new high of 14.02 on Friday, which worked out to a 108% upswing in a matter of less than a month.

Extended Watchlist:
RJDG, ATNM, INPX, NSPR, GNL, OTIV, CLSD, MYSZ